Celadon Pharmaceuticals Plc engages in the research, cultivation, manufacturing, and sale of cannabis-based medicines. The company primarily focuses on growing indoor hydroponic cannabis for use in medicinal products used to treat chronic pain, as well as autism spectrum disorders. Celadon Pharmaceuticals Plc was founded in 2018 and is headquartered in London, the United Kingdom.
Stock data | 2024 | Change |
---|---|---|
Price | $0.4493669213079221 | N/A |
Market Cap | $28.85M | N/A |
Shares Outstanding | 64.21M | N/A |
Employees | 24.00 | N/A |